# DoD Kidney Cancer, Clinical Trial Award

Source: https://welltoldgrants.com/grants/w81xwh-22-kcrp-cta-dod-kidney-cancer-clinical-trial-award/  
Official notice: https://www.grants.gov/search-results-detail/341145

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 3 awards worth $8.0 million in total. Applications closed on October 20, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-KCRP-CTA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 20, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 3 |
| Total funding | $8.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The KCRP Clinical Trial Award supports the rapid implementation of early-phase clinical trials (phase 0, phase 1, phase 1/2) with the potential to have a significant impact on the treatment or management of kidney cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, surgical procedures, behavior modifications, clinical guidance, and/or emerging approaches and technologies. Therapeutic approaches testing existing interventions for new indications in kidney cancer are also encouraged. It is anticipated that outcomes from studies funded by this award will provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform kidney cancer patient care. Funding from this award mechanism must support a clinical trial. A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. For more information, a Human Subject Resource Document is provided at https://cdmrp.army.mil/pubs/pdf/ Human%20Subjects%20Resource%20Document.pdf. Principal Investigators (PIs) seeking funding for a preclinical research project should consider one of the other FY22 KCRP program announcements being offered. Cell Therapy Focus Option (New for FY22): The FY22 KCRP Clinical Trial Award may support cell therapy clinical trials. Such studies may require additional resources due to required optimization of cell therapy manufacturing or clinical trial correlative studies. Applicants may request higher levels of funding within the defined period of performance. The application must demonstrate access to the necessary specimens and/or data of the proposed cohort. Appropriate access must be confirmed at the time of application submission. Qualified Collaboration Option (New for FY22): The KCRP will offer a Qualified Collaboration Option to encourage leveraging of existing infrastructure previously funded.

## Questions people ask

### Is W81XWH-22-KCRP-CTA still open?

No. It closed on October 20, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Kidney Cancer, Clinical Trial Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Kidney Cancer, Clinical Trial Award?

Closed October 20, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $8.0 million in total across about 3 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.